Compound ID | 83
EDP-788
Class: Macrolide
| Agent Type: | Synthetic; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against infections caused by Gram-positives including methicillin-resistant Staphylococcus aureus |
| Description: | A bicyclic macrolide |
| Institute where first reported: | Enata Pharmaceuticals, USA |
| Year first mentioned: | 2013 |
| Highest development stage: | Phase 1 (NCT02255968) |
| Development status: | Inactive |
| Reason dropped: | Terminated clinical trial |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.